Too often, politicians leave out the fine print when telling voters about the policies they're pushing for. The fine print in the $2 trillion spending bill moving through Congress gives me pause.
Included is a big change to Medicare that would profoundly disrupt the development of new treatments and cures. The change would allow federal officials to "negotiate" drug prices with pharmaceutical companies.
The effort sounds innocuous and has obvious appeal. Who could object to negotiations?